{{one source|date=August 2014}}
{{ref improve|date=August 2014}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 437202104
| IUPAC_name = 5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
| image = Brodimoprim.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 56518-41-3
| ATC_prefix = J01
| ATC_suffix = EA02
| PubChem = 68760
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 62004
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = V1YC7T6LLI
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07238
| ChEBI = 131726
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 31891

<!--Chemical data-->
| C=13 | H=15 | Br=1 | N=4 | O=2 
| molecular_weight = 339.188 g/mol
| smiles = Brc1c(OC)cc(cc1OC)Cc2cnc(nc2N)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H15BrN4O2/c1-19-9-4-7(5-10(20-2)11(9)14)3-8-6-17-13(16)18-12(8)15/h4-6H,3H2,1-2H3,(H4,15,16,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BFCRRLMMHNLSCP-UHFFFAOYSA-N
}}
'''Brodimoprim''' is a structural derivative of [[trimethoprim]]. In brodimoprim, the 4-[[methoxy]] group of trimethoprim is [[substitution (chemistry)|replaced]] with a [[bromine]] atom.

As trimethoprim, brodimoprim is a selective [[enzyme inhibitor|inhibitor]] of [[bacteria]]l [[dihydrofolate reductase]].<ref>{{cite journal |author=Thomson CJ |title=Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria |journal=J Chemother |volume=5 |issue=6 |pages=458â€“64 |year=1993 |pmid=8195838 |doi=}}</ref>

==References==
{{Reflist}}

{{Sulfonamides and trimethoprim}}

[[Category:Bacterial dihydrofolate reductase inhibitors]]
[[Category:Pyrimidines]]
[[Category:Phenol ethers]]
[[Category:Organobromides]]


{{antibiotic-stub}}